Crypto

Rezolve AI (RZLV) Valuation Check After Surging Q1 Revenue And New SQD Token Revolut Listing


Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Rezolve AI (RZLV) just paired a sharp Q1 2026 revenue jump with a fresh crypto access story, reporting US$60 million in unaudited first quarter revenue and securing a Revolut listing for its SQD token.

See our latest analysis for Rezolve AI.

Rezolve AI’s recent SQD listing on Revolut and reaffirmed 2026 revenue guidance have arrived alongside mixed price action, with a 1-day share price return of 3.9% but a 30-day share price return decline of 14.2%. Meanwhile, the 1-year total shareholder return of 18.1% contrasts with a 3-year total shareholder return loss of 73.6%, suggesting that short term momentum is rebuilding after a difficult multi year period.

If Rezolve AI’s crypto and AI commerce push has your attention, it can be useful to see what else is moving in related themes through 25 cryptocurrency and blockchain stocks

With Rezolve AI trading at US$2.67, showing a very large discount to its analyst price target yet also carrying an intrinsic premium, you have to ask: is there still mispricing here, or is the market already baking in future growth?

Most Popular Narrative: 73.3% Undervalued

Rezolve AI’s latest close at $2.67 sits well below the most followed narrative’s fair value of $10.00, setting up a bold growth story built on AI driven commerce and aggressive ARR scaling.

Rapid enterprise adoption of AI driven commerce tools, evidenced by Rezolve scaling from a standing start to $90 million in annual recurring revenue and more than 100 enterprise customers in under a year, creates a long runway for contracted subscription growth that can compound reported revenue and earnings.

Read the complete narrative.

Curious what justifies a fair value far above today’s price? The narrative leans heavily on expectations for steep revenue expansion, margin repair and a future earnings multiple that is described as comparable to high growth software. The assumptions are presented as punchy, and very specific, around how fast ARR compounds, how margins reset and how the valuation multiple holds up.

Result: Fair Value of $10 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, this hinges on Rezolve AI hitting ambitious ARR and earnings targets, as well as acquisitions and partner led sales scaling smoothly without integration or execution setbacks.

Find out about the key risks to this Rezolve AI narrative.

Another View: Market Multiple Sends A Very Different Signal

The narrative points to a fair value of $10, yet Rezolve AI already trades on a P/S of 22.8x, versus 3.8x for the wider US Software group and 5.3x for peers. The fair ratio, however, sits much higher at 63.9x. That gap leaves a wide range of possible outcomes, so which side of it do you trust?

To see how this pricing stacks up against detailed ratio work, take a closer look at the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGM:RZLV P/S Ratio as at May 2026

Next Steps

Mixed signals or a clear message, this update hints at both risk and opportunity, so it makes sense to move quickly and weigh the 1 key reward and 3 important warning signs

Looking for more investment ideas?

If Rezolve AI has you thinking about what else could be worth your attention, do not stop here, there are other opportunities worth lining up next.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include RZLV.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top